jw001JW Pharmaceutical has presented positive preclinical data on JW0061, a novel Wnt-targeted hair loss treatment, at the U.S. Society of Investative Dermatology meeting. What are Wnt-Targeted Hair LossN164JW a 2003 WARD JOHN R RV6A (owned by HI MOTORSPORTS INC) aircraft registration information, photos, accident history and more.